Prediction model for brain age may help detect cognitive decline
Jul 01, 2021
Greater differences between predicted age based on brain MRI and actual age were seen in those with amnestic mild cognitive impairment versus healthy controls.
Family availability impacts formal, informal dementia care
Sep 08, 2021
“The development of a care system that integrates informal with formal care has been considered essential for a sustainable healthcare system, especially one providing dementia care,” the authors...
PTSD, TBI interact with APOE ε4 to raise Alzheimer, dementia risk
Jan 06, 2023
Significant additive APOE ε4 interactions were seen with PTSD and TBI in veterans of European ancestry.
Trial begins of nasal vaccine for Alzheimer’s disease
Nov 18, 2021
Phase 1 trial will include 16 patients ages 60 to 85 years who have early, symptomatic Alzheimer disease but are otherwise in good health
Home discharge down, mortality increased after ICU stay for dementia patients
Jul 17, 2023
Older adults with Alzheimer’s disease and related dementia have lower rates of home discharge and higher mortality.
Cognitive impairment delayed with genetic variant
Jun 20, 2024
The onset of cognitive impairment was delayed among those heterozygous for the apolipoprotein E3 Christchurch variant.
Second death in trial of experimental Alzheimer’s drug raising concerns
Nov 29, 2022
Doctors suspect that by stripping away amyloid deposits, lecanemab weakens blood vessels and leaves them vulnerable to bleeds.
Ethical considerations explored for aducanumab in Alzheimer’s disease
Nov 19, 2021
Grounds are insufficient to offer aducanumab (Aduhelm) for moderate, advanced Alzheimer’s dementia or for individuals without biomarker evidence of brain ß-amyloid, according to a position statement.
Inverse link found for antioxidant levels, all-cause dementia
May 04, 2022
Serum lutein+zeaxanthin and β-cryptoxanthin levels were inversely associated with incident all-cause dementia.
Retinal layer thickness linked to cognitive decline in older adults
May 27, 2022
Thinner baseline total macular retinal nerve fiber layer thickness was associated with a larger decline in cognitive function test scores during follow-up.